Current Weather
The Spy FM

With Cancer Care, The U.S. Spends More, But Gets More

Filed by KOSU News in US News.
April 9, 2012

By now it’s hardly news that the U.S. spends more than every other industrialized country on health care. But a new study suggests that at least when it comes to cancer care, Americans may actually be getting decent value.

The study, in April issue of the policy journal Health Affairs, isn’t the first to suggest that U.S. patients do better than their European counterparts when it comes to surviving most types of cancer. Other studies have shown that the U.S. approves cancer drugs faster than most nations across the pond.

But this study, by researchers from the University of Chicago and the University of Southern California and partially funded by the cancer drugmaker Bristol-Myers Squibb, actually attempted to quantify what the U.S. gets for the additional money it spends.

And what it found is that for most types of solid tumor cancers, particularly breast and prostate cancer, even after considering the higher costs, U.S. patients experienced greater survival gains than patients in Europe.

And those costs did grow. Between 1983 and 1999, the period covered by the study, U.S. spending on cancer care grew 49 percent (in 2010 dollars). By comparison, spending in the 10 European countries included in the study grew by 16 percent. But for patients diagnosed between 1995 and 1999, average survival from time of diagnosis in the U.S. was 11.1 years, while in Europe it was 9.3 years.

“Using conservative market estimates of the value of a statistical life, this study presented evidence that U.S. cancer survival gains are worth more than the corresponding growth in the cost of U.S. cancer care according to the most recent data available for analysis,” the study’s authors wrote.

There are some significant caveats, of course. One is that that “most recent data” ends in 1999. And, they note, “important changes in cancer care have occurred in the past ten years, including the introduction of expensive new drug treatment and increased use of diagnostic imaging.”

So, the authors point out, it will take still more research to determine if today’s increased spending is still worth it, and what specific aspects of cancer care are driving the U.S.’s improved survival rates. [Copyright 2012 National Public Radio]

Leave a Reply

5AM to 9AM Morning Edition

Morning Edition

For more than two decades, NPR's Morning Edition has prepared listeners for the day ahead with two hours of up-to-the-minute news, background analysis, commentary, and coverage of arts and sports.

Listen Live Now!

9AM to 10AM The Takeaway

The Takeaway

A fresh alternative in morning news, "The Takeaway" provides a breadth and depth of world, national and regional news coverage that is unprecedented in public media.

View the program guide!

10AM to 11PM On Point

On Point

On Point unites distinct and provocative voices with passionate discussion as it confronts the stories that are at the center of what is important in the world today. Leaving no perspective unchallenged, On Point digs past the surface and into the core of a subject, exposing each of its real world implications.

View the program guide!

Upcoming Events in your area (Submit your event today!)

Streaming audio and podcasts

Stream KOSU on your smartphone

Phone Streaming

SmartPhone listening options on this page are intended for many iPhones, Blackberries, etc. with low-cost software applications available to listen to our full-time web streams, both News on KOSU-1 and Classical on KOSU-2.

Learn more about our complete range of streaming services

We're perfecting the patient experience - Stillwater Medical Center